Two Numbers on the Same Certificate, Two Different Measurements
Anyone who has compared certificates of analysis across a few research peptide suppliers has run into two figures that sound interchangeable but are not: purity percentage and net peptide content. Both appear on many COAs, both are expressed as percentages, and both are used to describe the quality of a lyophilized peptide. But they answer different questions, and conflating them leads to avoidable errors in study design, particularly anywhere a researcher needs to know the actual mass of peptide in a vial rather than just how clean that peptide is relative to itself.
What Purity Percentage Actually Measures
Purity percentage, as reported by reverse-phase HPLC, describes the composition of the peptide fraction only. During the assay, the sample is run through a column and detected by UV absorbance at a wavelength the peptide bond responds to. The instrument produces a chromatogram made up of peaks: one large peak corresponding to the target peptide, and smaller peaks corresponding to related impurities such as truncated sequences, deletion sequences, or diastereomers left over from synthesis.
The purity figure is the area under the target peak divided by the total area under all detected peaks. A result of 99% purity means that, of the material the detector can see and attribute to peptide-related species, 99% corresponds to the correct sequence. It says nothing about what fraction of the vial's total dry weight is peptide at all, because water, buffer salts, and counterions generally do not absorb at the same wavelength and do not show up as separate peaks in the same way.
What Net Peptide Content Measures
Net peptide content is a different calculation, typically derived from amino acid analysis, nitrogen determination, or a mass-balance approach. Instead of comparing peaks within a chromatogram, it asks what proportion of the total lyophilized powder, by weight, is actually peptide, as opposed to residual moisture, acetate or trifluoroacetate counterions from purification, and other non-peptide mass carried over from synthesis and lyophilization.
Synthetic peptides are rarely isolated as a pure free base. Most are isolated as a salt form, commonly an acetate or TFA salt, and that counterion contributes real mass to the powder in the vial without contributing any peptide. Add in residual water from incomplete lyophilization, and the gap between "how pure is the peptide" and "how much of this vial is peptide" can become substantial even when HPLC purity is very high.
Why a Vial Can Be Reported at High Purity but Lower Net Content
- The peptide fraction itself is genuinely clean, with few sequence-related impurities detected by HPLC.
- The salt form used during purification (acetate, TFA, or another counterion) adds non-peptide mass that HPLC purity does not account for.
- Residual moisture retained in the lyophilized cake adds further mass that is not peptide.
- Buffer components or excipients carried over from the final purification step contribute additional non-peptide weight.
None of this means the purity number is wrong. It means purity and net content are answering two separate questions, and a COA that reports only one of them is giving a researcher half the picture needed to calculate an accurate molar quantity.
How the Two Metrics Show Up on a Certificate of Analysis
Practices vary by supplier and by lab. Some certificates report HPLC purity only. Others report both purity and net peptide content, usually from a separate amino acid analysis or mass-based method, sometimes performed by a different laboratory than the one that ran the HPLC trace. Reading the document carefully, including the stated test method for each figure, matters as much as reading the number itself. Our guide on how to read a peptide certificate of analysis walks through the sections of a typical COA, including where purity and, when present, net content figures are usually located, and how they connect to a specific lot number. A vial such as BPC-157 illustrates the point well: the COA published for a given lot may report HPLC purity, net peptide content, or both, and the label distinguishes each metric by the test method used to generate it.
Because these figures can vary lot to lot even for the same catalog item, tracking which COA belongs to which vial matters. That connection is made through the lot number printed on the label, which is covered in more depth in our article on peptide lot numbers and batch traceability.
Where Net Peptide Content Matters in Calculation
Anywhere an experimental design calls for a specific molar concentration, the relevant quantity is the actual mass of peptide present in a weighed sample, not the total mass of powder weighed out. If a calculation assumes a weighed quantity of lyophilized material is close to 100% peptide by mass, but the material is actually a salt form with meaningful residual moisture and counterion content, the resulting molar concentration will be lower than the calculation assumed.
Molar Concentration Calculations
Net peptide content functions as a correction factor between gross powder weight and actual peptide mass. Multiplying a weighed mass by the net peptide content percentage gives a closer estimate of the true peptide mass present, which then feeds into a molarity calculation based on the compound's molecular weight. Omitting this correction is a plausible source of inter-lab variability when nominally identical concentrations are compared across research groups working from different lots or different suppliers.
Evaluating Which Metric a Supplier Reports
When comparing suppliers, it is worth checking a few specific things rather than treating a single purity number as the entire quality picture:
- Whether the COA reports purity, net peptide content, or both, and whether that is consistent across the supplier's catalog.
- What method was used for each figure, since HPLC purity and amino acid analysis are measuring different properties and are not interchangeable.
- Whether the COA is matched to the specific lot in hand, rather than a generic or representative document.
- Whether the testing was performed by an independent third-party laboratory or generated internally.
These questions overlap with the broader framework in our guide on how to evaluate a research peptide supplier, which covers documentation practices beyond just the purity figure. A compound such as Semax is a useful example of this in practice, since neuropeptides synthesized and purified through similar routes can show the same purity-versus-content gap described above.
Third-Party Testing and the Limits of a Single Number
Third-party testing adds confidence that a reported figure was not generated in-house, but it does not automatically mean every relevant metric was tested, or that purity and net content were both measured. A single third-party purity number confirms the peptide fraction is clean; it does not by itself confirm the net peptide content of the vial. Our article on what third-party testing actually proves goes further into what a given certificate does and does not establish, which is a useful companion to the purity-versus-content distinction covered here.
Genetic Peptides USA publishes certificates of analysis on the product pages where they are available, covering a portion of the catalog rather than every listing. Where a COA is published, it is worth checking which of these two metrics, or both, the document reports before using it in a calculation.
Practical Takeaways for Researchers
- Purity percentage describes how clean the peptide fraction is relative to itself, as measured by HPLC peak area.
- Net peptide content describes what fraction of the total powder weight is actually peptide, accounting for salts and moisture.
- A high purity figure does not guarantee a high net peptide content, and the two should not be used interchangeably in calculations.
- Molar concentration calculations for solution-based work should use net peptide content when it is available, not gross powder weight.
- When comparing compounds such as those examined in our NAD+ or GHK-Cu product documentation, checking which metrics a COA actually reports is part of due diligence, not an afterthought.
Researchers evaluating the full range of available research peptides can browse the complete catalog and review the documentation published for each listing.
For laboratory research use only. Not for human consumption.